Amy Elazzouzi

CIK: 0002042910

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (44.4%)

Position reduction

Option Exercises (M)7 (38.9%)

Derivative conversions

Awards (A)3 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AURA

Aura Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

AURA
Aura Biosciences, Inc.
Sep 1, 2026
Award(A)
Direct
23.5K shares-
AURA
Aura Biosciences, Inc.
Mar 2, 2026
Award(A)
Direct
44.5K shares-
AURA
Aura Biosciences, Inc.
Feb 17, 2026
Sale(S)
Direct
8.5K shares at avg. $5.06$43K
AURA
Aura Biosciences, Inc.
Jan 20, 2026
Sale(S)
Direct
1.6K shares at avg. $4.86$8K
AURA
Aura Biosciences, Inc.
Oct 29, 2025
Sale(S)
Direct
896 shares at avg. $6.35$6K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
4.7K shares at avg. $2.74$13K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
1.1K shares at avg. $3.16$3K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
2.3K shares at avg. $4.25$10K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Sale(S)
Direct
7.7K shares at avg. $6.70$52K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
547 shares at avg. $5.21$3K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
547 shares at avg. $5.48$3K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
1.1K shares at avg. $5.48$6K
AURA
Aura Biosciences, Inc.
Aug 18, 2025
Exercise(M)
Direct
2.6K shares at avg. $5.07$13K
AURA
Aura Biosciences, Inc.
Apr 16, 2025
Sale(S)
Direct
897 shares at avg. $5.49$5K
AURA
Aura Biosciences, Inc.
Feb 18, 2025
Sale(S)
Direct
1.4K shares at avg. $7.75$11K
AURA
Aura Biosciences, Inc.
Feb 3, 2025
Award(A)
Direct
45.2K shares-
AURA
Aura Biosciences, Inc.
Jan 21, 2025
Sale(S)
Direct
1K shares at avg. $7.67$8K
AURA
Aura Biosciences, Inc.
Oct 29, 2024
Sale(S)
Direct
553 shares at avg. $10.74$6K

		Type	Shares	Price		Ownership
Sep 1, 2026	AURA Aura Biosciences, Inc.	Award(A)	23,540	-	$0	Direct
Mar 2, 2026	AURA Aura Biosciences, Inc.	Award(A)	44,528	-	$0	Direct
Feb 17, 2026	AURA Aura Biosciences, Inc.	Sale(S)	8,549	$5.06	$43,258	Direct
Jan 20, 2026	AURA Aura Biosciences, Inc.	Sale(S)	1,581	$4.86	$7,684	Direct
Oct 29, 2025	AURA Aura Biosciences, Inc.	Sale(S)	896	$6.35	$5,690	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	4,744	$2.74	$12,999	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	1,094	$3.16	$3,457	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	2,319	$4.25	$9,856	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Sale(S)	7,722	$6.70	$51,737	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	547	$5.21	$2,850	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	547	$5.48	$2,998	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	1,094	$5.48	$5,995	Direct
Aug 18, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	2,554	$5.07	$12,949	Direct
Apr 16, 2025	AURA Aura Biosciences, Inc.	Sale(S)	897	$5.49	$4,925	Direct
Feb 18, 2025	AURA Aura Biosciences, Inc.	Sale(S)	1,404	$7.75	$10,881	Direct
Feb 3, 2025	AURA Aura Biosciences, Inc.	Award(A)	45,240	-	-	Direct
Jan 21, 2025	AURA Aura Biosciences, Inc.	Sale(S)	1,001	$7.67	$7,679	Direct
Oct 29, 2024	AURA Aura Biosciences, Inc.	Sale(S)	553	$10.74	$5,938	Direct

1-18 of 18 transactions

About Elazzouzi Amy

Elazzouzi Amy (SEC CIK 0002042910) files insider reports with the SEC as SVP, Finance & PAO of Aura Biosciences, Inc. (AURA).

Signal8 holds 12 ownership filings by Elazzouzi Amy (1 Form 3, 11 Form 4), filed between Oct 29, 2024 and Sep 1, 2026. Those filings report 18 transactions, from Oct 29, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Elazzouzi Amy's filings is in BOSTON, MA.

Recent filings by Elazzouzi Amy

Sep 1, 2026: Grant or award of AURA shares (Form 4, code A).
Mar 2, 2026: Grant or award of AURA shares (Form 4, code A).
Feb 17, 2026: Open-market sale of AURA shares (Form 4, code S).
Jan 20, 2026: Open-market sale of AURA shares (Form 4, code S).
Oct 29, 2025: Open-market sale of AURA shares (Form 4, code S).

Other insiders filing for Aura Biosciences, Inc. (AURA)

Person Julie, Chief People Officer
Kratz Erica, Chief Reg. & Quality Officer
Hopkins Janet Jill, Chief Medical Officer
Abu-Absi Susan, Chief Operating Officer
Bender Jeremy, Director
Kilroy Conor

How to read Form 4 transaction codes